UnitedHealth Group Incorporated
NYSE:UNH · New York Stock Exchange
+$3.69 today
Vol 11.68M · Avg 8.23M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $28.0B |
| Short-term Investments | $3.2B |
| Receivables | $51.2B |
| Other Current | $8.7B |
| Total Current Assets | $91.1B |
| PP&E (Net) | $10.7B |
| Goodwill | $110.5B |
| Intangible Assets | $20.1B |
| Long-term Investments | $56.8B |
| Other Non-current | $23.5B |
| Total Non-current Assets | $221.5B |
| Total Assets | $312.6B |
Analysis
Selected assets total $312.6B for Latest. The largest visible component is Goodwill at $110.5B, about 35.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.4B -3.7% | $25.3B -0.5% | $25.4B +8.8% | $23.4B +9.3% | $21.4B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $3.8B -1.2% | $3.8B -9.5% | $4.2B -7.6% | $4.5B +79.5% | $2.5B | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $52.7B +8.8% | $48.5B +24.3% | $39.0B +28.0% | $30.4B +8.4% | $28.1B | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 -100.0% | $8.2B -16.5% | $9.8B -8.1% | $10.7B +140.7% | $4.4B | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $90.6B +5.6% | $85.8B +9.4% | $78.4B +13.6% | $69.1B +11.8% | $61.8B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $10.8B +2.0% | $10.6B -7.8% | $11.4B +13.1% | $10.1B +12.9% | $9.0B | $1.2B | $1.5B | $687.8M |
| Goodwill | $110.5B +3.5% | $106.7B +2.9% | $103.7B +11.1% | $93.4B +23.2% | $75.8B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $20.5B -12.0% | $23.3B +53.1% | $15.2B +5.5% | $14.4B +43.4% | $10.0B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $54.3B +3.6% | $52.4B +10.0% | $47.6B +8.9% | $43.7B +1.4% | $43.1B | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 -100.0% | $2.8B +102.9% | -$94.8B | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $23.0B +17.5% | $19.6B +13.3% | $17.3B +41.1% | $12.3B -88.6% | $107.3B | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $219.0B +3.1% | $212.5B +8.8% | $195.3B +10.6% | $176.6B +17.4% | $150.4B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $309.6B +3.8% | $298.3B +9.0% | $273.7B +11.4% | $245.7B +15.8% | $212.2B | $13.3B | $11.9B | $10.6B |
| Account Payables | $38.0B -44.5% | $68.6B +114.5% | $32.0B -43.7% | $56.8B +15.6% | $49.1B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $6.1B +33.5% | $4.5B -14.4% | $5.3B +70.8% | $3.1B -14.1% | $3.6B | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $3.4B +2.9% | $3.3B -1.1% | $3.4B +9.1% | $3.1B +19.6% | $2.6B | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $28.0B +2.6% | $27.3B -53.2% | $58.4B +122.3% | $26.3B +14.4% | $23.0B | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $114.9B +10.7% | $103.8B +4.8% | $99.1B +11.0% | $89.2B +14.0% | $78.3B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $72.3B -0.1% | $72.4B +24.2% | $58.3B +6.9% | $54.5B +28.6% | $42.4B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 -100.0% | $3.6B +19.8% | $3.0B +9.1% | $2.8B -15.2% | $3.3B | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $2.4B | $0 -100.0% | $3.4B | $0 +100.0% | -$3.3B | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $18.2B +14.5% | $15.9B +33.5% | $11.9B -7.0% | $12.8B -14.7% | $15.1B | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $93.0B +1.2% | $91.9B +14.3% | $80.4B +14.7% | $70.1B +22.1% | $57.4B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $207.9B +6.2% | $195.7B +11.9% | $174.8B +9.7% | $159.4B +17.4% | $135.7B | $14.7B | $3.7B | $9.6B |
| Common Stock | $9.0M +0.0% | $9.0M +0.0% | $9.0M +0.0% | $9.0M -10.0% | $10.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $95.6B -0.5% | $96.0B +0.3% | $95.8B +11.2% | $86.2B +11.7% | $77.1B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$2.1B +39.1% | -$3.4B +51.8% | -$7.0B +16.3% | -$8.4B -55.9% | -$5.4B | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $7.6B -23.6% | $9.9B -2.3% | $10.2B +18.5% | $8.6B +81.7% | $4.7B | $1.4B | $337.8M | $931.4M |
| Total Equity | $101.7B -0.9% | $102.6B +3.7% | $98.9B +14.6% | $86.3B +12.9% | $76.5B | $9.1B | $7.7B | $3.3B |
| Total Debt | $78.4B +1.9% | $76.9B +14.0% | $67.4B +17.0% | $57.6B +25.3% | $46.0B | $724.2M | $410.6M | $399.4M |
| Net Debt | $54.0B +4.7% | $51.6B +22.8% | $42.0B +22.6% | $34.3B +39.1% | $24.6B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Merck & Co., Inc.
NYSE:MRK
$282.04B
Novartis AG
NYSE:NVS
$281.58B
AstraZeneca PLC
NYSE:AZN
$271.29B
Novo Nordisk A/S
NYSE:NVO
$191.37B
Thermo Fisher Scientific Inc.
NYSE:TMO
$173.12B
Abbott Laboratories
NYSE:ABT
$153.33B
CVS Health Corporation
NYSE:CVS
$125.86B
Elevance Health Inc.
NYSE:ELV
$84.44B
Cigna Corporation
NYSE:CI
$74.48B
Humana Inc.
NYSE:HUM
$43.87B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does UNH have?
UnitedHealth Group Incorporated (UNH) reported $24.36B in cash and equivalents in fiscal 2025.
How much debt does UNH carry?
UnitedHealth Group Incorporated (UNH) reported $78.39B of total debt, with net debt of $54.02B.
Explore More
Continue the stock analysis
Jump to another research area for this company.